Paper41465166
Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer.
Zou E and 9 others. Genes (Basel), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer. Papers, record 41465166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41465166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Head and Neck Neoplasms | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Humans | |
| Prognosis |
Source PubMed
References226
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26321370 | Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery. | Oral Oncol | 2015 | https://conductscience.org/library/papers/26321370 | PubMed |
| 2 | 33718169 | Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers. | Front Oncol | 2021 | https://conductscience.org/library/papers/33718169 | PubMed |
| 3 | 31027907 | Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes. | Pathol Res Pract | 2019 | https://conductscience.org/library/papers/31027907 | PubMed |
| 4 | 38440427 | p53, Cytokeratin 19 Expression in Oral Squamous Cell Carcinoma and Correlation with Histopathologic Grading: An Immunohistochemical Study. | Indian J Otolaryngol Head Neck Surg | 2024 | https://conductscience.org/library/papers/38440427 | PubMed |
| 5 | 12193474 | STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. | Cell Growth Differ | 2002 | https://conductscience.org/library/papers/12193474 | PubMed |
| 6 | 33750196 | Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33750196 | PubMed |
| 7 | 33668576 | Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression. | Cells | 2021 | https://conductscience.org/library/papers/33668576 | PubMed |
| 8 | 37856951 | Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis. | Ann Diagn Pathol | 2023 | https://conductscience.org/library/papers/37856951 | PubMed |
| 9 | 31618129 | Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/31618129 | PubMed |
| 10 | 17487385 | HPV infection and the alterations of the pRB pathway in oral carcinogenesis. | Oncol Rep | 2007 | https://conductscience.org/library/papers/17487385 | PubMed |
| 11 | 26449430 | Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma. | Med Oral Patol Oral Cir Bucal | 2015 | https://conductscience.org/library/papers/26449430 | PubMed |
| 12 | 15254063 | The biology and clinical relevance of the PTEN tumor suppressor pathway. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15254063 | PubMed |
| 13 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 14 | 28645102 | Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters. | Arch Oral Biol | 2017 | https://conductscience.org/library/papers/28645102 | PubMed |
| 15 | 36588838 | Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma. | J Oral Maxillofac Pathol | 2022 | https://conductscience.org/library/papers/36588838 | PubMed |
| 16 | 33989559 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33989559 | PubMed |
| 17 | 28090172 | THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION. | Cell Health Cytoskelet | 2015 | https://conductscience.org/library/papers/28090172 | PubMed |
| 18 | 34359680 | Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC). | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359680 | PubMed |
| 19 | 29954411 | Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters. | World J Surg Oncol | 2018 | https://conductscience.org/library/papers/29954411 | PubMed |
| 20 | 29117785 | Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion. | Cell Cycle | 2018 | https://conductscience.org/library/papers/29117785 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42907645 | Mass Spectrometry-Based Oral Meta-Omics Analysis-What We Know and What We Don't. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42907645 | PubMed |
| 42652223 | Tumor Biomarkers in Head and Neck Squamous Cell Carcinoma: From Etiology and Pathogenesis to Treatment Response-A Scoping Review. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652223 | PubMed |
| 42643993 | The Diagnostic and Prognostic Utility of Heat Shock Protein 27 as a Biomarker for Oral Squamous Cell Carcinoma. | Cureus | 2026 | https://conductscience.org/library/papers/42643993 | PubMed |
| 41977145 | Molecular Mechanisms in Oral Squamous Cell Carcinoma: Integrative Roles of Cancer-Associated Fibroblasts, Immune Microenvironment, and Precision Therapeutic Opportunities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977145 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41465166
GET https://conductscience.org/api/papers/v1/41465166/references?page=2